Plasmapheresis is a well-accepted treatment option in severe hypertriglyceridemia-induced pancreatitis (HTGP). The rationale behind this approach is the depletion of triglycerides and the reduction of inflammatory cytokines. The time span between onset of clinical symptoms and start of plasmapheresis might have an important impact on mortality. Hyperviscosity of patients' plasma represents another special challenge for the applied separation technology. The procedures can be performed either by centrifugal device (CFD) or membrane based (MBS) units. The present study reports the outcome of 10 patients suffering from HTG. The expected mortality of the collective was 25%. Plasmapheresis was started after an average 16.3 h (SD ± 6.7 h) after onset of symptoms. No mortality occurred. Apheresis was statistically equally effective with both devices. A median of 3 sessions reduced the TG level to normal and correlated with patients' improvement. During follow up, three patients developed a pancreatic pseudocyst requiring surgical intervention without further complication.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/1744-9987.12286 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Hypertriglyceridemia-induced Acute Pancreatitis: A Case Report.
Curr Cardiol Rev
January 2025
Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, China.
Background: Managing hypertriglyceridemia-induced acute pancreatitis (HTG-AP) can be challenging, particularly due to the need for rapid triglyceride reduction to below 500mg/dL (5.645mmol/L).
Case Report: This is a case describing a 39-year-old female patient who presented to the Emergency Department with acute abdominal pain resulting from severe HTG-AP.
fertilization-induced extreme hypertriglyceridemia with secondary acute pancreatitis in emergency department: A case report and literature review.
Turk J Emerg Med
October 2024
Medical Intensive Care Unit, 108 Military Central Hospital, Ha Noi, Vietnam.
Acute pancreatitis is one of the severe complications of hypertriglyceridemia, which needs to be recognized early to provide appropriate treatment. Hypertriglyceridemia-induced pancreatitis has several causes, in which fertilization (IVF) is a rare etiology that is becoming increasingly popular. We report a 33-year-old female patient with a history of hypertension who has failed an IVF cycle and started a new IVF procedure 1 month before admission.
View Article and Find Full Text PDFHypertriglyceridemia-induced acute pancreatitis in pregnancy associated with CREB3L3 mutation.
J Clin Lipidol
October 2024
Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:
A 40-year-old woman at 35 weeks of gestation presented with abdominal pain and hypertriglyceridemia of above 5000 mg/dL. Following lab tests and imaging studies, she was diagnosed with hypertriglyceridemia-related acute pancreatitis in pregnancy. She was managed with NPO, IV insulin, and peripheral parenteral nutrition, but her condition further complicated with preeclampsia, and she was induced and delivered at 36 weeks of gestation.
View Article and Find Full Text PDFOlanzapine is an antipsychotic medication that is used in the management of schizophrenia and bipolar disorder, but it is not without any adverse effects. We present the following case of a 24-year-old man with a history of schizoaffective disorder, obesity, and anxiety, who developed hypertriglyceridemia-induced acute pancreatitis after six months on olanzapine. Despite his adherence to the medication, routine metabolic monitoring was not performed leading to a delayed diagnosis of hypertriglyceridemia and subsequent complications.
View Article and Find Full Text PDFHypertriglyceridemia-Induced Acute Pancreatitis in Pregnancy: A Case Report in Anesthetic Management.
Cureus
September 2024
Anesthesiology, Albert Einstein College of Medicine, Bronx, USA.
Severe hypertriglyceridemia in pregnancy, defined as triglycerides >1000 mg/dL, is a rare but high-acuity condition that can precipitate several complications for the mother and fetus, in particular hypertriglyceridemia-induced acute pancreatitis (HTGAP). The treatments employed in the management of hypertriglyceridemia-induced acute pancreatitis (HTGAP) have the potential to significantly alter the anesthetic course of an impending or emergent delivery. In this report, we present two cases of HTGAP, one complicated by a concomitant COVID-19 infection and each with a unique approach to anesthetic management in the setting of two very different and cofounded clinical presentations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!